Loading
TruAlt Bioenergy Stock: price and insider trades · India
IN·Mcap ₹37.4B
1 insider bought €2.9M of shares over the last 90 days, the latest filed 30 Sept 2026.
TruAlt Bioenergy: what insiders have been doing
TruAlt Bioenergy is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). From 18 October 2025 to 18 October 2026, the disclosure feed for TruAlt Bioenergy logged 19 filings by 8 insiders.
The flow runs one way only: 1 insider bought (11 purchases totalling €2.9M) and nobody sold on the market. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 major shareholder among the declarants. Biggest ticket of the year: €612k, bought by Nirani Holdings Private Limited and made public on 25 September 2026 (0.18% of market cap).
The last purchase on record was published on 30 September 2026, which is 18 days ago. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (1,985 companies, median 4 filings), a count of 19 filings is above the norm. The full history, which starts in 2025, counts 11 purchases against no sales.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Insider Decl.
21
Thresholds
n/a
Buy Volume
€3M
11 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleNirani Holdings Private Limited11 buys
Since the insiders bought
- -14.3%Entry ₹489.20 · Close at T+30 ₹419.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,164 of 24,148 companies
34.5
score / 100
Value31
Quality38
FCF yld-22%
Earn yld2.6%
EV/EBITDA14.5x
ROE·
Gross mgn25%
Net mgn5.7%
Debt/EBITDA4.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹436.10
Analyst consensus
Income statement
Revenue₹17B
Gross profit₹4.3B25% margin
EBITDA₹3.7B22% margin
Net income₹959.5M7.2% margin
Valuation
PER (trailing)23.5x
P/Book2.5x
Balance sheet & cash
Market cap₹37.4B
Total debt₹16.5B
Free Cash Flow-₹8.1B
Debt / Equity105%
Profitability & ownership
% insiders74.7%
% institutions7.8%
Last declaration on 30 September 2026
Declarations21 total
196,129 shares00.0000% mcap0.0% of flowEquityMarket PurchaseSEBI:e1f7610b85f11f647b7f42a40b654b6d33784b50
Canonical exit: 29 Dec 2026 (T+90)
122,032 shares@ ₹456.700.14% mcap6.2% of flowEquityMarket PurchaseSEBI:4630bd6919b2276e747ef7a79f2db662b228d731
Canonical exit: 27 Dec 2026 (T+90)
300,000 shares@ ₹439.000.34% mcap100.0% of flowEquityPledge CreationSEBI:867b8ae6fcce712f04cffa72daa935ca09e9fa19
152,201 shares@ ₹439.300.18% mcap8.0% of flowEquityMarket PurchaseSEBI:58410c639c10c01337fce3ff6ee875abdf67d2b6
Canonical exit: 24 Dec 2026 (T+90)
1,400,000 shares@ ₹415.001.53% mcap69.2% of flowEquityPledge CreationSEBI:f2e766a9f986d7ceec1e9a57e52cb167dd597aea
50,000 shares@ ₹424.600.056% mcap2.5% of flowEquityMarket PurchaseSEBI:dc01974763aac07535928c295be38479c14a4884
Canonical exit: 16 Dec 2026 (T+90)
69,575 shares@ ₹422.300.076% mcap3.4% of flowEquityMarket PurchaseSEBI:6747ff413ec6cea79befeb1e7269ecc2d4dab89a
Canonical exit: 15 Dec 2026 (T+90)
98,700 shares@ ₹410.900.11% mcap4.8% of flowEquityMarket PurchaseSEBI:2a4e74b2aae8f6aa98a74889603e1bc0f664598c
Canonical exit: 14 Dec 2026 (T+90)
20,000 shares@ ₹467.600.025% mcap1.1% of flowEquityMarket PurchaseSEBI:9398b5ecf7776c5ed5d30c6e6fd700ff3f4ffa44
Canonical exit: 11 Nov 2026 (T+90)
24,200 shares@ ₹478.400.030% mcap1.4% of flowEquityMarket PurchaseSEBI:b3e665e12afee498a4ba7397179b680b66541ccd
Canonical exit: 10 Nov 2026 (T+90)
57,801 shares@ ₹478.200.072% mcap3.3% of flowEquityMarket PurchaseSEBI:f4754d5149cb0291de886e1b7c106e9f319f4a4d
Canonical exit: 8 Nov 2026 (T+90)
91,705 shares@ ₹476.100.11% mcap5.2% of flowEquityMarket PurchaseSEBI:18f4e5405beda988281eb3f4cfe9d23e4d4cd985
Canonical exit: 5 Nov 2026 (T+90)
21,600 shares@ ₹463.000.026% mcap1.2% of flowEquityMarket PurchaseSEBI:5fa72099f37cc381356f59a3c043b57085d9a8ff
Canonical exit: 5 Nov 2026 (T+90)
●
Same trade as the filing by Sangamesh Rudrappa Nirani, counted once · View ↗
2,500,000 shares@ ₹471.7573.8% of flowEquity SharesSEBI:1a535af796098819c9caf3a06ee4a999ff0642d1
2,500,000 shares@ ₹471.7573.8% of flowEquity SharesSEBI:386acb164c81677ecfd3f8d8921b56cb89871c99
1,010,025 shares@ ₹413.1026.2% of flowEquity SharesSEBI:482c5c5b9e44227b66987c586247b363714a0435
●
Same trade as the filing by Dhraksayani Sangamesh Nirani, counted once · View ↗
1,010,025 shares@ ₹413.1026.2% of flowEquity SharesSEBI:86cd0d0aac36dd0c9031cab10bb8792b440421af
3,903,146 shares@ ₹413.10100.0% of flowEquity SharesSEBI:1ef08fb785189e6881ca45748fa1b77bacd613ee
3,790,826 shares@ ₹413.10100.0% of flowEquity SharesSEBI:3ae9633649333130107ccfa843d65411988bf319
3,790,826 shares@ ₹413.10100.0% of flowEquity SharesSEBI:853521f1ad9e6b88864016ce4c99f35d31febbac
3,790,826 shares@ ₹413.10100.0% of flowEquity SharesSEBI:cccb23405517838fb08c838c66484ab1f6548d88
21 of 21 declarations
About TruAlt Bioenergy
TruAlt Bioenergy is a company focused on producing renewable energy from biological resources. It operates in the XBOM market.
